Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphatic Malformation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03547830
What this trial is testing

Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients

Who this might be right for
Chronic Granulomatous Disease
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 17
Large-scale testing (Phase 3)Study completedNCT02174900
What this trial is testing

Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 70
Large-scale testing (Phase 3)Active Not RecruitingNCT00319228
What this trial is testing

Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate

Who this might be right for
Antithrombin III Deficiency
Grifols Biologicals, LLC 30
Not applicableStudy completedNCT02069236
What this trial is testing

Comparing G6PD Tests Using Capillary Blood Versus Venous Blood

Who this might be right for
Glucose-6 Phosphate Dehydrogenase Deficiency
PATH 150
Early research (Phase 1)Study completedNCT04878731
What this trial is testing

Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia

Who this might be right for
Severe Hemophilia
Pfizer 6
Not applicableEnrolling By InvitationNCT03836300
What this trial is testing

Parent and Infant Inter(X)Action Intervention (PIXI)

Who this might be right for
Fragile X SyndromeAngelman SyndromePrader-Willi Syndrome+11 more
RTI International 120
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT06198712
What this trial is testing

Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Forma Therapeutics, Inc. 95
Large-scale testing (Phase 3)Ended earlyNCT03040765
What this trial is testing

Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis

Who this might be right for
Thalassemia Majors (Beta-Thalassemia Major)Osteoporosis
Hamad Medical Corporation 17
Not applicableStudy completedNCT00895154
What this trial is testing

A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study

Who this might be right for
Sickle Cell Disease
Washington University School of Medicine 21
Not applicableStudy completedNCT06357572
What this trial is testing

Real-life Clinical FEIBA Samples Measured Using the Version A of the HemA EnzySystem

Who this might be right for
Hemophilia A With InhibitorHemophilia A
Enzyre B.V. 6
Not applicableLooking for participantsNCT07206095
What this trial is testing

Integrative Diagnosis for SCD and Other RADs

Who this might be right for
Sickle Cell DiseaseThalassaemiaCongenital Dyserythropoietic Anemia (CDA)+6 more
Hospital Universitari Vall d'Hebron Research Institute 200
Testing effectiveness (Phase 2)Ended earlyNCT02013375
What this trial is testing

SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD

Who this might be right for
Sickle Cell Disease
Damiano Rondelli, MD 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07711158
What this trial is testing

A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency

Who this might be right for
Factor VII Deficiency
Shanghai RAAS Blood Products Co., Ltd. 12
Not applicableEnded earlyNCT03387033
What this trial is testing

Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell DiseaseVirtual RealityAnxiety+2 more
Duke University 20
Not applicableUnknownNCT05476458
What this trial is testing

To Evaluate Efficacy of Red Dichromatic Imaging (RDI) in Achieving Hemostasis During POEM Using GF 1500 UGI Scope

Who this might be right for
POEMS SyndromeHemostatic Disorder
Asian Institute of Gastroenterology, India 100
Testing effectiveness (Phase 2)Study completedNCT01732718
What this trial is testing

Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell Nephropathy
University of North Carolina, Chapel Hill 13
Post-approval studies (Phase 4)Study completedNCT00581126
What this trial is testing

Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 14
Testing effectiveness (Phase 2)WithdrawnNCT04938635
What this trial is testing

Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia

Who this might be right for
Beta-Thalassemia
Vifor (International) Inc.
Next Page